Impact of exposure reduction recommendations on asthma symptom control during the high desert dust season in Cyprus: The MEDEA randomised trial in children with asthma
P. Kouis (Nicosia, Cyprus), P. Kinni (Nicosia, Cyprus), A. Michanikou (Nicosia, Cyprus), P. Anagnostopoulou (Nicosia, Cyprus), K. Pitsios (Nicosia, Cyprus), M. Kakkoura (Nicosia, Cyprus), S. Papatheodorou (Boston, United States), P. Koutrakis (Boston, United States), P. Yiallouros (Nicosia, Cyprus)
Source: International Congress 2022 – Predictors of lung function and respiratory morbidity in children
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kouis (Nicosia, Cyprus), P. Kinni (Nicosia, Cyprus), A. Michanikou (Nicosia, Cyprus), P. Anagnostopoulou (Nicosia, Cyprus), K. Pitsios (Nicosia, Cyprus), M. Kakkoura (Nicosia, Cyprus), S. Papatheodorou (Boston, United States), P. Koutrakis (Boston, United States), P. Yiallouros (Nicosia, Cyprus). Impact of exposure reduction recommendations on asthma symptom control during the high desert dust season in Cyprus: The MEDEA randomised trial in children with asthma. 1004
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|